nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Bexarotene—hematologic cancer	0.0578	0.0829	CbGbCtD
Tasosartan—CYP3A4—Lomustine—hematologic cancer	0.0538	0.0771	CbGbCtD
Tasosartan—CYP3A4—Busulfan—hematologic cancer	0.0538	0.0771	CbGbCtD
Tasosartan—CYP3A4—Thiotepa—hematologic cancer	0.0479	0.0687	CbGbCtD
Tasosartan—CYP3A4—Methoxsalen—hematologic cancer	0.0373	0.0534	CbGbCtD
Tasosartan—CYP3A4—Bortezomib—hematologic cancer	0.0354	0.0508	CbGbCtD
Tasosartan—CYP3A4—Daunorubicin—hematologic cancer	0.0339	0.0486	CbGbCtD
Tasosartan—CYP3A4—Cytarabine—hematologic cancer	0.0299	0.0429	CbGbCtD
Tasosartan—CYP3A4—Teniposide—hematologic cancer	0.0295	0.0422	CbGbCtD
Tasosartan—AGTR2—hematopoietic system—hematologic cancer	0.0289	0.323	CbGeAlD
Tasosartan—CYP3A4—Ifosfamide—hematologic cancer	0.0272	0.039	CbGbCtD
Tasosartan—CYP3A4—Imatinib—hematologic cancer	0.026	0.0372	CbGbCtD
Tasosartan—CYP3A4—Ruxolitinib—hematologic cancer	0.0244	0.0351	CbGbCtD
Tasosartan—CYP3A4—Nilotinib—hematologic cancer	0.0236	0.0338	CbGbCtD
Tasosartan—CYP3A4—Vinorelbine—hematologic cancer	0.0234	0.0335	CbGbCtD
Tasosartan—CYP3A4—Triamcinolone—hematologic cancer	0.0214	0.0307	CbGbCtD
Tasosartan—CYP3A4—Dasatinib—hematologic cancer	0.0209	0.0299	CbGbCtD
Tasosartan—CYP3A4—Mitoxantrone—hematologic cancer	0.0206	0.0295	CbGbCtD
Tasosartan—AGTR2—blood—hematologic cancer	0.0192	0.214	CbGeAlD
Tasosartan—CYP3A4—Betamethasone—hematologic cancer	0.0184	0.0263	CbGbCtD
Tasosartan—CYP3A4—Prednisolone—hematologic cancer	0.0181	0.026	CbGbCtD
Tasosartan—CYP3A4—Prednisone—hematologic cancer	0.0171	0.0245	CbGbCtD
Tasosartan—AGTR2—lung—hematologic cancer	0.0168	0.188	CbGeAlD
Tasosartan—CYP3A4—Irinotecan—hematologic cancer	0.0162	0.0232	CbGbCtD
Tasosartan—CYP3A4—Vinblastine—hematologic cancer	0.0144	0.0207	CbGbCtD
Tasosartan—CYP3A4—Vincristine—hematologic cancer	0.0142	0.0203	CbGbCtD
Tasosartan—CYP3A4—Etoposide—hematologic cancer	0.013	0.0186	CbGbCtD
Tasosartan—CYP3A4—Dexamethasone—hematologic cancer	0.0107	0.0153	CbGbCtD
Tasosartan—CYP3A4—Doxorubicin—hematologic cancer	0.00886	0.0127	CbGbCtD
Tasosartan—AGTR1—hematopoietic system—hematologic cancer	0.00648	0.0724	CbGeAlD
Tasosartan—AGTR1—blood—hematologic cancer	0.00429	0.0479	CbGeAlD
Tasosartan—AGTR1—lung—hematologic cancer	0.00376	0.042	CbGeAlD
Tasosartan—AGTR1—testis—hematologic cancer	0.00355	0.0397	CbGeAlD
Tasosartan—Irbesartan—JUN—hematologic cancer	0.003	0.525	CrCbGaD
Tasosartan—AGTR1—lymph node—hematologic cancer	0.00257	0.0287	CbGeAlD
Tasosartan—CYP3A4—hematopoietic system—hematologic cancer	0.00238	0.0266	CbGeAlD
Tasosartan—CYP3A4—blood—hematologic cancer	0.00158	0.0176	CbGeAlD
Tasosartan—Losartan—UGT1A1—hematologic cancer	0.00116	0.203	CrCbGaD
Tasosartan—Valsartan—ALB—hematologic cancer	0.000582	0.102	CrCbGaD
Tasosartan—Candesartan—ABCB1—hematologic cancer	0.000421	0.0736	CrCbGaD
Tasosartan—Losartan—ALB—hematologic cancer	0.000284	0.0497	CrCbGaD
Tasosartan—Losartan—ABCB1—hematologic cancer	0.000271	0.0474	CrCbGaD
Tasosartan—AGTR1—Signaling Pathways—CRKL—hematologic cancer	8.06e-05	0.000389	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6R—hematologic cancer	8.03e-05	0.000387	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CREBBP—hematologic cancer	8.02e-05	0.000387	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—MTR—hematologic cancer	7.92e-05	0.000382	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RASGRP1—hematologic cancer	7.91e-05	0.000381	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GRB2—hematologic cancer	7.83e-05	0.000378	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RGS2—hematologic cancer	7.77e-05	0.000375	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—hematologic cancer	7.7e-05	0.000372	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CMA1—hematologic cancer	7.68e-05	0.000371	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TRH—hematologic cancer	7.68e-05	0.000371	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TRIO—hematologic cancer	7.68e-05	0.000371	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAP2K1—hematologic cancer	7.65e-05	0.000369	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CD—hematologic cancer	7.6e-05	0.000367	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	7.53e-05	0.000364	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CA—hematologic cancer	7.53e-05	0.000363	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AGO2—hematologic cancer	7.52e-05	0.000363	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SPHK1—hematologic cancer	7.52e-05	0.000363	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KRAS—hematologic cancer	7.44e-05	0.000359	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LPAR1—hematologic cancer	7.44e-05	0.000359	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HDAC9—hematologic cancer	7.44e-05	0.000359	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—H3F3B—hematologic cancer	7.37e-05	0.000355	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGF2—hematologic cancer	7.28e-05	0.000351	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3R1—hematologic cancer	7.18e-05	0.000346	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—hematologic cancer	7.12e-05	0.000344	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GRB2—hematologic cancer	7.11e-05	0.000343	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CSF2—hematologic cancer	7e-05	0.000338	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JAK2—hematologic cancer	6.98e-05	0.000337	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CNR2—hematologic cancer	6.85e-05	0.00033	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDE4B—hematologic cancer	6.85e-05	0.00033	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CA—hematologic cancer	6.84e-05	0.00033	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hematologic cancer	6.82e-05	0.000329	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MDM2—hematologic cancer	6.81e-05	0.000329	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGF19—hematologic cancer	6.79e-05	0.000328	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PRKCG—hematologic cancer	6.75e-05	0.000326	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—JAK1—hematologic cancer	6.75e-05	0.000326	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RAC2—hematologic cancer	6.74e-05	0.000325	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DKK1—hematologic cancer	6.69e-05	0.000323	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT5B—hematologic cancer	6.63e-05	0.00032	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MTOR—hematologic cancer	6.63e-05	0.00032	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CB—hematologic cancer	6.63e-05	0.00032	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADCY7—hematologic cancer	6.44e-05	0.000311	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CSF2—hematologic cancer	6.35e-05	0.000307	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HRAS—hematologic cancer	6.33e-05	0.000305	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2RA—hematologic cancer	6.31e-05	0.000304	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—XIAP—hematologic cancer	6.26e-05	0.000302	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1B—hematologic cancer	6.22e-05	0.0003	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT1—hematologic cancer	6.15e-05	0.000297	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—JAK1—hematologic cancer	6.13e-05	0.000296	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRKCG—hematologic cancer	6.13e-05	0.000296	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SMARCA4—hematologic cancer	6.1e-05	0.000295	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SH2B3—hematologic cancer	6.1e-05	0.000295	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—hematologic cancer	6.1e-05	0.000294	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—hematologic cancer	6.09e-05	0.000294	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GZMB—hematologic cancer	6.07e-05	0.000293	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—hematologic cancer	6.06e-05	0.000292	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCND1—hematologic cancer	5.93e-05	0.000286	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CTNNA1—hematologic cancer	5.92e-05	0.000286	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JUN—hematologic cancer	5.92e-05	0.000286	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HSPB1—hematologic cancer	5.89e-05	0.000284	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL3—hematologic cancer	5.89e-05	0.000284	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EIF4EBP1—hematologic cancer	5.89e-05	0.000284	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTHLH—hematologic cancer	5.82e-05	0.000281	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SDC1—hematologic cancer	5.82e-05	0.000281	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1A—hematologic cancer	5.74e-05	0.000277	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTEN—hematologic cancer	5.73e-05	0.000276	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2RA—hematologic cancer	5.73e-05	0.000276	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTGER4—hematologic cancer	5.67e-05	0.000274	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LCK—hematologic cancer	5.64e-05	0.000272	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK8—hematologic cancer	5.6e-05	0.00027	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT1—hematologic cancer	5.59e-05	0.00027	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—H3F3A—hematologic cancer	5.53e-05	0.000267	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EP300—hematologic cancer	5.46e-05	0.000264	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCZ—hematologic cancer	5.37e-05	0.000259	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SRC—hematologic cancer	5.31e-05	0.000256	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CG—hematologic cancer	5.25e-05	0.000253	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	5.22e-05	0.000252	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PARP1—hematologic cancer	5.19e-05	0.00025	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—hematologic cancer	5.17e-05	0.00025	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	5.15e-05	0.000249	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STAT3—hematologic cancer	5.12e-05	0.000247	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NRAS—hematologic cancer	5.11e-05	0.000247	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FBXW7—hematologic cancer	5.11e-05	0.000246	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HDAC2—hematologic cancer	5.01e-05	0.000242	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCR4—hematologic cancer	5.01e-05	0.000242	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK3—hematologic cancer	4.89e-05	0.000236	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CBL—hematologic cancer	4.88e-05	0.000235	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL3—hematologic cancer	4.83e-05	0.000233	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	4.8e-05	0.000232	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CG—hematologic cancer	4.77e-05	0.00023	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MYC—hematologic cancer	4.76e-05	0.00023	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTPN1—hematologic cancer	4.75e-05	0.000229	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—hematologic cancer	4.75e-05	0.000229	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	4.73e-05	0.000228	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PTPN11—hematologic cancer	4.69e-05	0.000226	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RASGRP1—hematologic cancer	4.67e-05	0.000225	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SYK—hematologic cancer	4.66e-05	0.000225	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HSP90AA1—hematologic cancer	4.66e-05	0.000225	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CD—hematologic cancer	4.62e-05	0.000223	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CREB1—hematologic cancer	4.54e-05	0.000219	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT1—hematologic cancer	4.49e-05	0.000217	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL2—hematologic cancer	4.44e-05	0.000214	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6R—hematologic cancer	4.43e-05	0.000214	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KRAS—hematologic cancer	4.4e-05	0.000212	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3R1—hematologic cancer	4.36e-05	0.00021	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—JAK2—hematologic cancer	4.24e-05	0.000204	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAP2K1—hematologic cancer	4.22e-05	0.000204	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRB2—hematologic cancer	4.2e-05	0.000203	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CD—hematologic cancer	4.19e-05	0.000202	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFA—hematologic cancer	4.19e-05	0.000202	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KITLG—hematologic cancer	4.13e-05	0.000199	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CA—hematologic cancer	4.04e-05	0.000195	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT5A—hematologic cancer	4.04e-05	0.000195	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CB—hematologic cancer	4.03e-05	0.000194	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—FTCD—hematologic cancer	4e-05	0.000193	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PHYH—hematologic cancer	4e-05	0.000193	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GMPS—hematologic cancer	4e-05	0.000193	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN2B—hematologic cancer	4e-05	0.000193	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3R1—hematologic cancer	3.96e-05	0.000191	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—hematologic cancer	3.91e-05	0.000189	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CD86—hematologic cancer	3.87e-05	0.000187	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—JAK2—hematologic cancer	3.85e-05	0.000186	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HES1—hematologic cancer	3.82e-05	0.000184	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NCOR1—hematologic cancer	3.8e-05	0.000183	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGF1—hematologic cancer	3.75e-05	0.000181	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CSF2—hematologic cancer	3.75e-05	0.000181	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HRAS—hematologic cancer	3.74e-05	0.00018	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FOXO1—hematologic cancer	3.7e-05	0.000178	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—hematologic cancer	3.7e-05	0.000178	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFRB—hematologic cancer	3.69e-05	0.000178	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SMPD3—hematologic cancer	3.66e-05	0.000177	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CB—hematologic cancer	3.66e-05	0.000176	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFRA—hematologic cancer	3.63e-05	0.000175	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JAK1—hematologic cancer	3.62e-05	0.000175	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCG—hematologic cancer	3.62e-05	0.000175	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—hematologic cancer	3.58e-05	0.000173	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2RA—hematologic cancer	3.38e-05	0.000163	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—hematologic cancer	3.36e-05	0.000162	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TERT—hematologic cancer	3.34e-05	0.000161	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—hematologic cancer	3.3e-05	0.000159	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFB—hematologic cancer	3.26e-05	0.000158	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—B3GAT1—hematologic cancer	3.2e-05	0.000154	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ASNS—hematologic cancer	3.2e-05	0.000154	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DCK—hematologic cancer	3.2e-05	0.000154	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TSC2—hematologic cancer	3.19e-05	0.000154	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGFR3—hematologic cancer	3.07e-05	0.000148	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK14—hematologic cancer	3.04e-05	0.000147	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HDC—hematologic cancer	3.03e-05	0.000146	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ESR1—hematologic cancer	2.98e-05	0.000144	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FN1—hematologic cancer	2.94e-05	0.000142	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BAD—hematologic cancer	2.91e-05	0.00014	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NFKBIA—hematologic cancer	2.91e-05	0.00014	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH1—hematologic cancer	2.88e-05	0.000139	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CD80—hematologic cancer	2.82e-05	0.000136	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CG—hematologic cancer	2.82e-05	0.000136	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KIT—hematologic cancer	2.82e-05	0.000136	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NRAS—hematologic cancer	2.82e-05	0.000136	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CDA—hematologic cancer	2.77e-05	0.000134	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTPN11—hematologic cancer	2.77e-05	0.000134	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAPK3—hematologic cancer	2.7e-05	0.00013	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CREB1—hematologic cancer	2.68e-05	0.000129	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PC—hematologic cancer	2.67e-05	0.000129	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BRAF—hematologic cancer	2.65e-05	0.000128	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL2—hematologic cancer	2.62e-05	0.000127	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6R—hematologic cancer	2.62e-05	0.000126	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CREBBP—hematologic cancer	2.61e-05	0.000126	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GBA—hematologic cancer	2.58e-05	0.000124	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC35B2—hematologic cancer	2.58e-05	0.000124	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAP2K1—hematologic cancer	2.49e-05	0.00012	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CD—hematologic cancer	2.48e-05	0.00012	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.45e-05	0.000118	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KRAS—hematologic cancer	2.43e-05	0.000117	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGF2—hematologic cancer	2.37e-05	0.000114	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTAP—hematologic cancer	2.36e-05	0.000114	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3R1—hematologic cancer	2.34e-05	0.000113	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JAK2—hematologic cancer	2.27e-05	0.00011	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CA—hematologic cancer	2.23e-05	0.000108	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MDM2—hematologic cancer	2.22e-05	0.000107	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MTOR—hematologic cancer	2.16e-05	0.000104	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CB—hematologic cancer	2.16e-05	0.000104	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—FHL2—hematologic cancer	2.1e-05	0.000101	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HRAS—hematologic cancer	2.06e-05	9.95e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AGRN—hematologic cancer	2.06e-05	9.95e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1B—hematologic cancer	2.03e-05	9.78e-05	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—hematologic cancer	2e-05	9.67e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—hematologic cancer	1.99e-05	9.58e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—hematologic cancer	1.98e-05	9.57e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—hematologic cancer	1.97e-05	9.52e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—IDH2—hematologic cancer	1.95e-05	9.43e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HMMR—hematologic cancer	1.95e-05	9.43e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCND1—hematologic cancer	1.93e-05	9.33e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JUN—hematologic cancer	1.93e-05	9.31e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1A—hematologic cancer	1.87e-05	9.02e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTEN—hematologic cancer	1.87e-05	9e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.84e-05	8.87e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK8—hematologic cancer	1.83e-05	8.81e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—hematologic cancer	1.82e-05	8.78e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CA9—hematologic cancer	1.79e-05	8.62e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ACP5—hematologic cancer	1.79e-05	8.62e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EP300—hematologic cancer	1.78e-05	8.59e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.76e-05	8.51e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SRC—hematologic cancer	1.73e-05	8.35e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—hematologic cancer	1.69e-05	8.13e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—IDH1—hematologic cancer	1.68e-05	8.11e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT3—hematologic cancer	1.67e-05	8.05e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NRAS—hematologic cancer	1.66e-05	8.03e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.66e-05	8.02e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TXN—hematologic cancer	1.66e-05	8.02e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.66e-05	8.02e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.63e-05	7.85e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK3—hematologic cancer	1.59e-05	7.69e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.56e-05	7.54e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MYC—hematologic cancer	1.55e-05	7.48e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—hematologic cancer	1.55e-05	7.46e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.52e-05	7.33e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.52e-05	7.33e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.48e-05	7.15e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NUP98—hematologic cancer	1.43e-05	6.92e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KRAS—hematologic cancer	1.43e-05	6.91e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.39e-05	6.72e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.39e-05	6.72e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NUP214—hematologic cancer	1.38e-05	6.67e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTR—hematologic cancer	1.35e-05	6.54e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.35e-05	6.54e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ENO2—hematologic cancer	1.33e-05	6.41e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CA—hematologic cancer	1.32e-05	6.35e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.29e-05	6.22e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—hematologic cancer	1.27e-05	6.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SDC1—hematologic cancer	1.26e-05	6.08e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRAS—hematologic cancer	1.22e-05	5.88e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—hematologic cancer	1.17e-05	5.62e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—hematologic cancer	1.08e-05	5.19e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NQO1—hematologic cancer	1.07e-05	5.17e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CD44—hematologic cancer	1.07e-05	5.17e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYCS—hematologic cancer	1.01e-05	4.89e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.01e-05	4.86e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTP1—hematologic cancer	8.93e-06	4.31e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCB1—hematologic cancer	8.45e-06	4.08e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NCOR1—hematologic cancer	8.21e-06	3.96e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM1—hematologic cancer	8.21e-06	3.96e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTHFR—hematologic cancer	7.25e-06	3.5e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CG—hematologic cancer	6.09e-06	2.94e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CREBBP—hematologic cancer	5.65e-06	2.73e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CD—hematologic cancer	5.36e-06	2.58e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—hematologic cancer	5.29e-06	2.55e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.06e-06	2.44e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CB—hematologic cancer	4.67e-06	2.25e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTEN—hematologic cancer	4.04e-06	1.95e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—EP300—hematologic cancer	3.85e-06	1.86e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.85e-06	1.37e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—hematologic cancer	2.33e-06	1.12e-05	CbGpPWpGaD
